✦ LIBER ✦

High-Dose Naltrexone Therapy for Cocaine-Alcohol Dependence

✍ Scribed by Joy M. Schmitz; Jan A. Lindsay; Charles E. Green; David V. Herin; Angela L. Stotts; F. Gerard Moeller

Book ID: 111737587
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 153 KB
Volume: 18
Category: Article
ISSN: 1055-0496
DOI: 10.1080/10550490903077929

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gender differences with high-dose naltre

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence

✍ Helen M. Pettinati; Kyle M. Kampman; Kevin G. Lynch; Jesse J. Suh; Charles A. Da 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Gender Differences in Predictors of Trea

Gender Differences in Predictors of Treatment Attrition with High Dose Naltrexone in Cocaine and Alcohol Dependence

✍ Jesse J. Suh; Helen M. Pettinati; Kyle M. Kampman; Charles P. O'Brien 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 79 KB

High-dose naltrexone therapy and dietary

High-dose naltrexone therapy and dietary counseling for obesity

✍ James E. Mitchell; John E. Morley; Alan S. Levine; Dorothy Hatsukami; Mary Ganno 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 647 KB

Naltrexone for alcohol-dependent patient

Naltrexone for alcohol-dependent patients

✍ J Ahmadi; M Babaeebeigi; I Maany; J Porter; M Mohagheghzadeh; N Ahmadi; G Dehboz 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 319 KB

High-Dose Baclofen for Suppression of Al

High-Dose Baclofen for Suppression of Alcohol Dependence

✍ Olivier Ameisen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Safety, tolerability, and feasibility of

Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study

✍ Gihyun Yoon; Suck Won Kim; Paul Thuras; Joseph Westermeyer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Objective Prior trials testing standard-dose naltrexone (50 mg/day) have generated mixed results in the treatment of alcohol dependence. The purpose of this study was to evaluate the short-term safety, tolerability, and feasibility of high-dose naltrexone (150 mg/day) for treating alcohol-dependent